Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PROMETHAZINE HYDROCHLORIDE PLAIN | ANI Pharmaceuticals | N-008381 DISCN | 1982-01-01 | 2 products, RLD |
PHENERGAN | Delcor Asset | N-007935 DISCN | 1982-01-01 | 3 products, RLD |
PHENERGAN | Mylan | N-010926 DISCN | 1982-01-01 | 2 products, RLD |
PHENERGAN | Mylan | N-011689 DISCN | 1982-01-01 | 1 products, RLD |
PHENERGAN | Wyeth | N-008857 DISCN | 1982-01-01 | 2 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PHENERGAN W/ CODEINE | ANI Pharmaceuticals | N-008306 DISCN | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PHENERGAN VC W/ CODEINE | ANI Pharmaceuticals | N-008306 DISCN | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PHENERGAN VC | ANI Pharmaceuticals | N-008604 DISCN | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | ANI Pharmaceuticals | N-011265 RX | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MEPERGAN | Hikma Pharmaceuticals | N-011730 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
dextromethorphan hydrobromide and promethazine hydrochloride | ANDA | 2024-06-05 |
phenadoz | ANDA | 2021-03-01 |
phenergan | ANDA | 2024-08-09 |
prometh with codeine | ANDA | 2012-01-24 |
promethazine | ANDA | 2022-10-08 |
promethazine and codeine | ANDA | 2009-08-21 |
promethazine dm | ANDA | 2020-12-16 |
promethazine hci | ANDA | 2024-02-22 |
promethazine hcl | ANDA | 2019-11-26 |
promethazine hcl promethazine hydrochloride | 2006-11-27 |
Code | Description |
---|---|
J2180 | Injection, meperidine and promethazine hcl, up to 50 mg |
J2550 | Injection, promethazine hcl, up to 50 mg |
Q0169 | Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Nausea | D009325 | HP_0002018 | R11.0 | — | 2 | 5 | 6 | 7 | 20 |
Headache | D006261 | HP_0002315 | R51 | 2 | 4 | 4 | 7 | 4 | 19 |
Vomiting | D014839 | HP_0002013 | R11.1 | — | 2 | 5 | 4 | 6 | 17 |
Migraine disorders | D008881 | EFO_0003821 | G43 | 1 | 3 | 4 | 5 | 4 | 16 |
Sleep initiation and maintenance disorders | D007319 | — | F51.01 | 1 | 2 | 3 | 2 | 4 | 12 |
Pruritus | D011537 | HP_0000989 | L29 | 2 | 4 | 1 | 2 | 3 | 10 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 1 | 5 | — | 1 | 1 | 8 |
Hepatitis | D006505 | HP_0012115 | K75.9 | 1 | 5 | — | 1 | 1 | 8 |
Depression | D003863 | — | F33.9 | 1 | 1 | 1 | 1 | 4 | 8 |
Kidney transplantation | D016030 | — | — | 2 | 6 | — | 1 | — | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 8 | 15 | 1 | — | 1 | 24 |
Multiple myeloma | D009101 | — | C90.0 | 6 | 11 | 3 | — | 1 | 20 |
Neoplasms | D009369 | — | C80 | 5 | 13 | 1 | — | — | 19 |
Plasma cell neoplasms | D054219 | — | — | 5 | 10 | 3 | — | 1 | 18 |
Pain | D010146 | EFO_0003843 | R52 | 3 | 2 | 5 | — | 4 | 14 |
Healthy volunteers/patients | — | — | — | 10 | — | 1 | — | 3 | 14 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 4 | 9 | 1 | — | 1 | 14 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 3 | 6 | 5 | — | — | 12 |
Syndrome | D013577 | — | — | 1 | 6 | 2 | — | 3 | 11 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 6 | 2 | — | 2 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 11 | 12 | — | — | 2 | 24 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | — | 5 | 6 | — | — | 1 | 11 |
Lymphoid leukemia | D007945 | — | C91 | 4 | 6 | — | — | 1 | 11 |
Hematologic neoplasms | D019337 | — | — | 1 | 6 | — | — | 1 | 8 |
Hepatitis b | D006509 | — | — | 1 | 5 | — | — | 2 | 8 |
Hepatitis a | D006506 | EFO_0007305 | B15 | 1 | 5 | — | — | 1 | 7 |
B-cell lymphoma | D016393 | — | — | 4 | 3 | — | — | — | 7 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 3 | 4 | — | — | — | 7 |
Myeloid leukemia acute | D015470 | — | C92.0 | 4 | 3 | — | — | — | 6 |
Myeloid leukemia | D007951 | — | C92 | 4 | 2 | — | — | — | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | — | 3 | — | — | — | 1 | 4 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | 3 | — | — | — | — | 3 |
Fever | D005334 | HP_0001945 | R50.9 | 2 | — | — | — | — | 2 |
Alcohol-related disorders | D019973 | — | F10 | 1 | — | — | — | 1 | 2 |
Hypotension | D007022 | EFO_0005251 | I95 | 1 | — | — | — | — | 1 |
Pure autonomic failure | D054970 | — | — | 1 | — | — | — | — | 1 |
Orthostatic hypotension | D007024 | — | I95.1 | 1 | — | — | — | — | 1 |
Systemic mastocytosis | D034721 | — | C96.21 | 1 | — | — | — | — | 1 |
Oral lichen planus | D017676 | — | — | 1 | — | — | — | — | 1 |
Lichen planus | D008010 | — | L43 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sleep wake disorders | D012893 | — | G47 | — | — | — | — | 5 | 5 |
Wounds and injuries | D014947 | — | T14.8 | — | — | — | — | 3 | 3 |
Dyssomnias | D020920 | — | — | — | — | — | — | 3 | 3 |
Parasomnias | D020447 | — | G47.5 | — | — | — | — | 3 | 3 |
Delirium | D003693 | — | R41.0 | — | — | — | — | 2 | 2 |
Infections | D007239 | EFO_0000544 | — | — | — | — | — | 2 | 2 |
Communicable diseases | D003141 | — | — | — | — | — | — | 2 | 2 |
Chronic pain | D059350 | HP_0012532 | — | — | — | — | — | 2 | 2 |
Suicidal ideation | D059020 | EFO_0004320 | R45.851 | — | — | — | — | 2 | 2 |
Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | — | 2 | 2 |
Drug common name | Promethazine |
INN | promethazine |
Description | Promethazine is a tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety. It has a role as a H1-receptor antagonist, a sedative, an antiemetic, a local anaesthetic, an antipruritic drug, an anti-allergic agent and an anticoronaviral agent. It is a member of phenothiazines and a tertiary amine. It is a conjugate base of a promethazine(1+). |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(CN1c2ccccc2Sc2ccccc21)N(C)C |
PDB | — |
CAS-ID | 60-87-7 |
RxCUI | — |
ChEMBL ID | CHEMBL643 |
ChEBI ID | 8461 |
PubChem CID | 4927 |
DrugBank | DB01069 |
UNII ID | FF28EJQ494 (ChemIDplus, GSRS) |